240-OR: Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data

KARIM S. HAIDER; AHMAD HAIDER; FARID SAAD

doi:10.2337/db21-240-or

240-OR: Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data

Diabetes ◽

10.2337/db21-240-or ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 240-OR

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Diabetic Complications ◽

Real World ◽

Term Treatment ◽

Real World Data ◽

Testosterone Undecanoate ◽

World Data ◽

Long Term Treatment

Download Full-text

1075-P: Long-Term Treatment with Testosterone Undecanoate Injections (TU) Improves Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data with 2,928 Patient-Years

Diabetes ◽

10.2337/db20-1075-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 1075-P

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Real World ◽

Term Treatment ◽

Real World Data ◽

Testosterone Undecanoate ◽

World Data ◽

Long Term Treatment

Download Full-text

401-P: Mortality, Major Adverse Cardiovascular Events (MACDE), and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): 11-Year Real-World Data

Diabetes ◽

10.2337/db20-401-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 401-P

Author(s):

AHMAD HAIDER ◽

KARIM S. HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Diabetic Complications ◽

Cardiovascular Events ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Real World Data ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review2 ◽

2020 ◽

Author(s):

Kuat Oshakbayev

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Author response for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/response1 ◽

2020 ◽

Author(s):

Karim Sultan Haider ◽

Ahmad Haider ◽

Farid Saad ◽

Gheorghe Doros ◽

Markolf Hanefeld ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Author Response ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review3 ◽

2020 ◽

Author(s):

Thomas Jones

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Decision letter for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

298-OR: Lipid Pattern in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison with an Untreated Control Group: Update of Real-World Registry Data

Diabetes ◽

10.2337/db21-298-or ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 298-OR

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Control Group ◽

Untreated Control Group ◽

Testosterone Undecanoate ◽

Long Term Treatment ◽

Lipid Pattern

Download Full-text

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v1/review5 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Decision letter for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v1/review1 ◽

2020 ◽

Author(s):

Thomas Jones

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text